LAWRENCE, Mass.--(BUSINESS WIRE)--Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced a major enhancement — the addition of user-changeable fluorescence optics modules — to Cellometer® Vision, its automated fluorescence-based imaging cell counter and analyzer.
